Prostatype Genomics presents Quarterly Report
Prostatype Genomics AB has today published its quarterly report for the first quarter comprising the period from 1 January 2023 to 31 March 2023. The report is available on the company website .Quarter 1 (1 January – 31 March 2023) summarized · Net sales amounted to 392 TSEK. · Net revenue amounted to 392 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -7 324 TSEK. · Cash flow from current operations in the quarter amounted -9 147 TSEK. · Total cash flow for the period amounted to -9 317 TSEK.